About Advanced Life Sciences
Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company’s lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-acquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia.
Company Fact Sheet
Company Overview Video
Press Room
About Sarms
Selective Androgen Receptor Modulators represent a promising avenue for advanced life sciences to improve therapeutic options and address various medical conditions. Their unique mechanism of action, tissue-specific targeting, and potential to mimic the beneficial effects of anabolic steroids without the associated side effects make them an intriguing area of research. These advancements hold great promise for athletes, bodybuilders, and patients suffering from various medical conditions. However, it is important to note that SARMs are still under investigation, and further research is needed to fully understand their long-term effects, optimal dosages, and potential risks. As research in this field continues to progress, we can expect SARMs to play a crucial role in shaping the future of sports, medicine, and overall human well-being.
Company Fact Sheet
Company Overview Video